Analytica Ltd. (ALT.AX)

ASX - ASX Delayed Price. Currency in AUD
0.01-0.00 (-12.50%)
As of 8:06 PM EDT. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.01
Bid0.01 x
Ask0.01 x
Day's Range0.01 - 0.01
52wk Range0.00 - 0.01
1y Target EstN/A
Market Cap15.66M
P/E Ratio (ttm)-2.33
Avg Vol (3m)1,535,902
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • PR Newswire3 months ago

    FDA approves PeriCoach® pelvic floor trainer for sale over-the-counter in the United States

    DENVER, July 13, 2016 /PRNewswire/ -- Analytica (ASX: ALT) today announced that the U.S. Food and Drug Administration (FDA) has approved the PeriCoach® at-home pelvic floor trainer device and smartphone app as an over-the-counter (OTC) treatment for treatment of mild, moderate and stress urinary incontinence (UI) and urge incontinence.  A strong pelvic floor is also associated with improved sexual function and satisfaction.

  • PR Newswirelast year

    What's YOUR "Kegel face?"

    Kegels are pelvic floor muscle training exercises and considered first line treatment for urinary incontinence (UI).  About one in three women will experience UI at some point in their lives, typically after childbirth and around menopause.

  • We're sorry this is all we were able to find about this topic.